Embecta Corp. (NASDAQ:EMBC) Shares Sold by Keeley Teton Advisors LLC

Keeley Teton Advisors LLC trimmed its holdings in Embecta Corp. (NASDAQ:EMBC) by 4.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 311,755 shares of the company’s stock after selling 14,633 shares during the period. Embecta accounts for approximately 0.7% of Keeley Teton Advisors LLC’s holdings, making the stock its 27th largest holding. Keeley Teton Advisors LLC’s holdings in Embecta were worth $6,438,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Smartleaf Asset Management LLC grew its holdings in Embecta by 175.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,216 shares of the company’s stock valued at $25,000 after purchasing an additional 774 shares during the period. Sterling Capital Management LLC grew its stake in shares of Embecta by 796.3% during the 4th quarter. Sterling Capital Management LLC now owns 1,685 shares of the company’s stock valued at $35,000 after buying an additional 1,497 shares during the period. Oppenheimer Asset Management Inc. acquired a new stake in shares of Embecta during the 4th quarter worth $209,000. KLP Kapitalforvaltning AS acquired a new position in Embecta in the fourth quarter valued at $215,000. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Embecta during the third quarter valued at about $217,000. Institutional investors and hedge funds own 93.83% of the company’s stock.

Insider Buying and Selling at Embecta

In related news, Director Milton Mayo Morris sold 3,100 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $16.38, for a total value of $50,778.00. Following the transaction, the director now owns 36,133 shares in the company, valued at approximately $591,858.54. The trade was a 7.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.42% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Separately, Mizuho started coverage on Embecta in a research note on Thursday, April 10th. They issued a “neutral” rating and a $15.00 price objective on the stock.

Embecta Trading Down 3.3 %

Shares of NASDAQ EMBC opened at $11.90 on Tuesday. The stock has a fifty day moving average price of $13.60 and a 200 day moving average price of $15.98. The company has a market cap of $691.79 million, a P/E ratio of 11.90, a P/E/G ratio of 0.78 and a beta of 1.23. Embecta Corp. has a 12-month low of $9.93 and a 12-month high of $21.48.

Embecta (NASDAQ:EMBC) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.45 by $0.20. Embecta had a negative return on equity of 19.22% and a net margin of 5.25%. On average, sell-side analysts forecast that Embecta Corp. will post 2.85 EPS for the current fiscal year.

Embecta Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a $0.15 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.60 dividend on an annualized basis and a yield of 5.04%. Embecta’s dividend payout ratio is currently 60.00%.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.